v3.25.2
Segment Reporting (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
segment
Jun. 30, 2024
USD ($)
Segment Reporting            
Number of operating segments | segment         1  
Number of reportable segments | segment         1  
External research and development expenses $ 7,248   $ 6,313   $ 22,590 $ 11,575
External General and administrative expenses 4,677   4,276   9,200 7,782
Stock-based compensation expense         3,070 2,208
Net loss (10,386) $ (18,176) (8,118) $ (6,629) (28,562) (14,747)
Operating segment            
Segment Reporting            
External General and administrative expenses 2,379   2,245   4,631 4,342
Personnel costs 1,775   1,516   3,726 2,994
Stock-based compensation expense 1,598   1,449   3,070 2,208
Other segment items (1,510)   (2,195)   $ (3,179) (4,091)
Other income - Description         Other segment items consist of (i) interest and other income, net and (ii) other internal operating research and development expenses  
Net loss (10,386)   (8,118)   $ (28,562) (14,747)
Operating segment | Denifanstat            
Segment Reporting            
External research and development expenses 4,758   5,088   18,094 9,279
Operating segment | TVB-3567            
Segment Reporting            
External research and development expenses $ 1,386   $ 15   $ 2,220 $ 15